90 related articles for article (PubMed ID: 18417980)
1. Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Fetal Diagn Ther; 2008; 23(3):211-6. PubMed ID: 18417980
[TBL] [Abstract][Full Text] [Related]
2. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome.
Sifakis S; Papadopoulou E; Konstantinidou A; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2009 Apr; 19(2):121-5. PubMed ID: 18793862
[TBL] [Abstract][Full Text] [Related]
4. Placental growth hormone in Down's syndrome screening.
Baviera G; Carbone C; Corrado F; Mastrantonio P
J Matern Fetal Neonatal Med; 2004 Oct; 16(4):241-3. PubMed ID: 15590454
[TBL] [Abstract][Full Text] [Related]
5. Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. International Prenatal Screening Research Group.
Wald NJ; Hackshaw AK; Diamandis EP; Melegos DN
Prenat Diagn; 1999 Jul; 19(7):674-6. PubMed ID: 10419619
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum placental growth hormone at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates.
Sifakis S; Akolekar R; Kappou D; Mantas N; Nicolaides KH
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1796-9. PubMed ID: 22489624
[TBL] [Abstract][Full Text] [Related]
7. Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome.
Christiansen M
Prenat Diagn; 2009 Dec; 29(13):1249-55. PubMed ID: 19844941
[TBL] [Abstract][Full Text] [Related]
8. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
Spencer K; Liao AW; Ong CY; Geerts L; Nicolaides KH
Prenat Diagn; 2001 Jun; 21(6):441-4. PubMed ID: 11438945
[TBL] [Abstract][Full Text] [Related]
10. Maternal plasma levels of follistatin-related gene protein in the first trimester of pregnancies with Down syndrome.
Miron P; Lambert J; Marcil A; Cowans NJ; Stamatopoulou A; Spencer K
Prenat Diagn; 2010 Mar; 30(3):224-8. PubMed ID: 20063262
[TBL] [Abstract][Full Text] [Related]
11. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
[TBL] [Abstract][Full Text] [Related]
12. Down syndrome maternal serum marker screening after 18 weeks' gestation.
Muller F; Dreux S; Oury JF; Luton D; Uzan S; Uzan M; Levardon M; Dommergues M
Prenat Diagn; 2002 Nov; 22(11):1001-4. PubMed ID: 12424764
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21.
Moghadam S; Engel W; Bougoussa M; Hennen G; Igout A; Sancken U
Fetal Diagn Ther; 1998; 13(5):291-7. PubMed ID: 9813422
[TBL] [Abstract][Full Text] [Related]
14. First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies.
Weinans MJ; Pratt JJ; de Wolf BT; Mantingh A
Prenat Diagn; 2001 Sep; 21(9):723-5. PubMed ID: 11559906
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum anti-Mullerian hormone level is not superior to chronological age in predicting Down syndrome pregnancies.
Li HW; Hui PW; Tang MH; Lau ET; Yeung WS; Ho PC; Ng EH
Prenat Diagn; 2010 Apr; 30(4):320-4. PubMed ID: 20155783
[TBL] [Abstract][Full Text] [Related]
16. Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome.
Cuckle HS; Shahabi S; Sehmi IK; Jones R; Cole LA
Prenat Diagn; 1999 Oct; 19(10):918-20. PubMed ID: 10521815
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
18. Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
Seifer DB; MacLaughlin DT; Cuckle HS
Hum Reprod; 2007 Apr; 22(4):1017-20. PubMed ID: 17218369
[TBL] [Abstract][Full Text] [Related]
19. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
20. Second-trimester maternal serum CA-125 versus estriol in the multiple-marker screening test for Down syndrome.
Wenstrom KD; Owen J; Boots L
Obstet Gynecol; 1997 Mar; 89(3):359-63. PubMed ID: 9052585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
